Titan further amends amalgamation agreement with conavi medical inc. and announces further extension of 2024 annual general and special meeting

Toronto, ontario, aug. 14, 2024 (globe newswire) -- titan medical inc. (“titan”) (tsx: tmd; otc: tmdif) is pleased to announce that it has entered into a third amending agreement dated august 13, 2024 (the “amending agreement no. 3”), in respect of the previously announced amalgamation agreement dated march 17, 2024, as previously amended on may 28, 2024 and on july 5, 2024 (collectively, the “amalgamation agreement”) among conavi medical inc. (“conavi”), 1000824255 ontario inc. (a wholly-owned subsidiary of titan) and titan, to result in the merger of conavi and titan (the “proposed transaction”). in addition, titan announces that the toronto stock exchange (“tsx”) has granted titan an extension to hold its annual general and special meeting of shareholders (the “agm”) on or before september 30, 2024.
GM Ratings Summary
GM Quant Ranking